Garat Chrystelle V, Fankell Dana, Erickson Paul F, Reusch Jane E-B, Bauer Natalie N, McMurtry Ivan F, Klemm Dwight J
Cardiovascular Pulmonary Research, University of Colorado Health Sciences Center, 4200 East Ninth Ave., Campus Box B-133, Denver, CO 80262, USA.
Mol Cell Biol. 2006 Jul;26(13):4934-48. doi: 10.1128/MCB.02477-05.
Cyclic AMP response element binding protein (CREB) content is diminished in smooth muscle cells (SMCs) in remodeled pulmonary arteries from animals with pulmonary hypertension and in the SMC layers of atherogenic systemic arteries and cardiomyocytes from hypertensive individuals. Loss of CREB can be induced in cultured SMCs by chronic exposure to hypoxia or platelet-derived growth factor BB (PDGF-BB). Here we investigated the signaling pathways and mechanisms by which PDGF elicits depletion of SMC CREB. Chronic PDGF treatment increased CREB ubiquitination in SMCs, while treatment of SMCs with the proteasome inhibitor lactacystin prevented decreases in CREB content. The nuclear export inhibitor leptomycin B also prevented depletion of SMC CREB alone or in combination with lactacystin. Subsequent studies showed that PDGF activated extracellular signal-regulated kinase, Jun N-terminal protein kinase, and phosphatidylinositol 3 (PI3)-kinase pathways in SMCs. Inhibition of these pathways blocked SMC proliferation in response to PDGF, but only inhibition of PI3-kinase or its effector, Akt, blocked PDGF-induced CREB loss. Finally, chimeric proteins containing enhanced cyan fluorescent protein linked to wild-type CREB or CREB molecules with mutations in several recognized phosphorylation sites were introduced into SMCs. PDGF treatment reduced the levels of each of these chimeric proteins except for one containing mutations in adjacent serine residues (serines 103 and 107), suggesting that CREB loss was dependent on CREB phosphorylation at these sites. We conclude that PDGF stimulates nuclear export and proteasomal degradation of CREB in SMCs via PI3-kinase/Akt signaling. These results indicate that in addition to direct phosphorylation, proteolysis and intracellular localization are key mechanisms regulating CREB content and activity in SMCs.
环磷酸腺苷反应元件结合蛋白(CREB)的含量在患有肺动脉高压动物的重塑肺动脉平滑肌细胞(SMC)、动脉粥样硬化性体动脉的SMC层以及高血压个体的心肌细胞中均减少。慢性暴露于低氧环境或血小板衍生生长因子BB(PDGF - BB)可诱导培养的SMC中CREB缺失。在此,我们研究了PDGF引发SMC中CREB耗竭的信号通路和机制。慢性PDGF处理增加了SMC中CREB的泛素化,而用蛋白酶体抑制剂乳胞素处理SMC可防止CREB含量降低。核输出抑制剂 leptomycin B单独或与乳胞素联合使用也可防止SMC中CREB的耗竭。随后的研究表明,PDGF激活了SMC中的细胞外信号调节激酶、Jun N末端蛋白激酶和磷脂酰肌醇3(PI3)-激酶通路。抑制这些通路可阻断SMC对PDGF的增殖反应,但只有抑制PI3 -激酶或其效应器Akt才能阻断PDGF诱导的CREB缺失。最后,将含有与野生型CREB或在几个公认的磷酸化位点发生突变的CREB分子相连的增强型青色荧光蛋白的嵌合蛋白导入SMC。PDGF处理降低了除一个在相邻丝氨酸残基(丝氨酸103和107)发生突变的嵌合蛋白外的每种嵌合蛋白的水平,这表明CREB的缺失依赖于这些位点的CREB磷酸化。我们得出结论,PDGF通过PI3 -激酶/Akt信号传导刺激SMC中CREB的核输出和蛋白酶体降解。这些结果表明,除了直接磷酸化外,蛋白水解和细胞内定位是调节SMC中CREB含量和活性的关键机制。